"10.1371_journal.pone.0147898","plos one","2016-02-03T00:00:00Z","Saku Väätäinen; Henna Cederberg; Risto Roine; Sirkka Keinänen-Kiukaanniemi; Jouko Saramies; Hannu Uusitalo; Jaakko Tuomilehto; Janne Martikainen","Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio, Finland; Department of Medicine, Kuopio University Hospital, Kuopio, Finland; Research Centre for Comparative Effectiveness and Patient Safety (RECEPS), Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland; Group Administration, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Center for Life Course Health research, University of Oulu, Oulu, Finland; Unit of Primary Health Care and Medical Research Center, Oulu University Hospital, Oulu, Finland; South Karelia Central Hospital, Lappeenranta, Finland; Department of Ophthalmology, SILK, School of Medicine, University of Tampere and TAUH Eye Center, Tampere Finland; Centre for Vascular Prevention, Danube-University Krems, Austria; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia; Dasman Diabetes Institute, Dasman, Kuwait","Conceived and designed the experiments: JS. Performed the experiments: JS. Analyzed the data: SV JM. Contributed reagents/materials/analysis tools: SV JS JM. Wrote the paper: SV HC RR JS SKK JS HU JT JM. researched the data, wrote the manuscript and prepared the tables and figures: SV. Contributed to interpretation of the data and reviewed the manuscript: HC JT. Contributed to discussion and critically reviewed the manuscript: RR SKK JS HU. Supervised the research and had a major role in manuscript preparation: JM.","SV is a paid employee of ESIOR Oy, which provides health economic and outcome research services to pharmaceutical and medical device companies. HC, RR, JS, HU, SKK declare no conflicts of interest. JT initiated and was involved in the development of the FINDRISC. JM is a partner of ESiOR Oy, which provides health economic and outcome research services to pharmaceutical and medical device companies. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","02","Saku Väätäinen","SV",8,TRUE,1,1,2,8,TRUE,TRUE,FALSE,0,NA,FALSE
